DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

Journal of Clinical Immunology

Volumn 35, Issue 2, 2015, Pages 189-198

  Aydin, Susanne E ^a   Kilic, Sara Sebnem ^b   Aytekin, Caner ^c   Kumar, Ashish ^d   Porras, Oscar ^e   Kainulainen, Leena ^f   Kostyuchenko, Larysa ^g   Genel, Ferah ^h   Kütükcüler, Necil ⁱ   Karaca, Neslihan ⁱ   Gonzalez Granado, Luis ^j   Abbott, Jordan ^k   Al Zahrani, Daifulah ^l   Rezaei, Nima ^m,n   Baz, Zeina ^o   Thiel, Jens ^p   Ehl, Stephan ^p   Marodi, László ^q   Orange, Jordan S ^r   Sawalle Belohradsky, Julie ^a   Keles, Sevgi ^s   Holland, Steven M ^t   Sanal, Özden ^u   Ayvaz, Deniz C ^u   Tezcan, Ilhan ^u   Al Mousa, Hamoud ^v   Alsum, Zobaida ^v   Hawwari, Abbas ^v   Metin, Ayse ^w   Matthes Martin, Susanne ^x   Hönig, Manfred ^y   Schulz, Ansgar ^y   Picard, Capucine ^z,aa   Barlogis, Vincent ^ab   Gennery, Andrew ^ac   Ifversen, Marianne ^ad   van Montfrans, Joris ^ae   Kuijpers, Taco ^af   Bredius, Robbert ^ag   Dückers, Gregor ^ah   Al Herz, Waleed ^ai,aj   Pai, Sung Yun ^ak,al   Geha, Raif ^ak   Notheis, Gundula ^a   Schwarze, Carl Philipp ^am   Tavil, Betül ^an   Azik, Fatih ^an   Bienemann, Kirsten ^ao   Grimbacher, Bodo ^p   Heinz, Valerie ^a   Gaspar, H Bobby ^ap   Aydin, Roland ^a   Hagl, Beate ^a   Gathmann, Benjamin ^p   Belohradsky, Bernd H ^a   Ochs, Hans D ^aq   Chatila, Talal ^ak   Renner, Ellen D ^a   Su, Helen ^p   Freeman, Alexandra F ^p   Engelhardt, Karin ^p   Albert, Michael H ^a   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ULUDAG UNIVERSITY   (Turkey)

^c DR SAMI ULUS MATERNITY AND CHILDREN S HEALTH AND DISEASES TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g Western Ukrainian Centre of Paediatric Immunology   (Ukraine)

^h Behcet Uz Children's Hospital   (Turkey)

ⁱ EGE UNIVERSITY   (Turkey)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^k UNIVERSITY OF COLORADO   (United States)

^l KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^m TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^o SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^p UNIVERSITY OF FREIBURG   (Germany)

^q UNIVERSITY OF DEBRECEN   (Hungary)

^r TEXAS CHILDREN S HOSPITAL   (United States)

^s NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^t NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^u HACETTEPE UNIVERSITY   (Turkey)

^v KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^w SB Ankara Diskapi Children's Hospital   (Turkey)

^x ST ANNA CHILDREN S HOSPITAL   (Austria)

^y UNIVERSITY HOSPITAL ULM   (Germany)

^z HÔPITAL NECKER ENFANTS MALADES   (France)

^aa IMAGINE INSTITUTE   (France)

^ab AIX MARSEILLE UNIVERSITY   (France)

^ac NEWCASTLE UNIVERSITY   (United Kingdom)

^ad Rigshospitalet   (Denmark)

^ae UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^af EMMA CHILDREN S HOSPITAL   (Netherlands)

^ag LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ah HELIOS Children's Hospital Krefeld   (Germany)

^ai KUWAIT UNIVERSITY   (Kuwait)

^aj AL SABAH HOSPITAL   (Kuwait)

^ak BOSTON CHILDREN S HOSPITAL   (United States)

^al DANA FARBER CANCER INSTITUTE   (United States)

^am UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^an ANKARA ONCOLOGY HOSPITAL   (Turkey)

^ao UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^ap UNIVERSITY COLLEGE LONDON   (United Kingdom)

^aq UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

combined immunodeficiency; DOCK8 deficiency; hyper IgE syndrome; natural outcome

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; DOCK8 PROTEIN; IMMUNOGLOBULIN; PROTEIN; UNCLASSIFIED DRUG; DOCK8 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; IMMUNOGLOBULIN E;

ADULT; ALLERGY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOCK8 DEFICIENCY; ECZEMA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS CANDIDIASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; ADOLESCENT; BLOOD; CHILD; COHORT ANALYSIS; COMPLICATION; DEFICIENCY; GENETIC ASSOCIATION; GENETICS; IMMUNOLOGY; INCIDENCE; INFANT; JOB SYNDROME; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; NEOPLASMS; PHENOTYPE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOGLOBULIN E; INCIDENCE; INFANT; INFECTION; JOB SYNDROME; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; PHENOTYPE; YOUNG ADULT;

EID: 84925543370     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0126-0     Document Type: Article

References (39)

1. Davis S, Schaller J, Wedgwood R, Harvard MD. Job’s syndrome. Lancet. 1966;287(7445):1013–5.
2. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59–70.
3. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections–an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692–702.
4. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608–19.
5. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058–62.
6. Renner ED, Torgerson TR, Rylaarsdam S, Anover-Sombke S, Golob K, LaFlam T, et al. STAT3 mutation in the original patient with job’s syndrome. N Engl J Med. 2007;357(16):1667–8.
7. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144(1):93–9.
8. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289--1302.
9. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046–55.
10. Al-Zahrani D, Raddadi A, Massaad M, Keles S, Jabara HH, Chatila TA, et al. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency. Clin Immunol. 2014;153(1):104–8.
11. Keles S, Jabara HH, Reisli I, McDonald DR, Barlan I, Hanna-Wakim R, et al. Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy. J Allergy Clin Immunol. 2014;133(6):1753–1755.
12. Papan C, Hagl B, Heinz V, Albert MH, Ehrt O, Sawalle-Belohradsky J, et al. Beneficial IFN-alpha treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2014;133(5):1456–8.
13. Bittner TC, Pannicke U, Renner ED, Notheis G, Hoffmann F, Belohradsky BH, et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Pädiatr. 2010;222(6):351–5.
14. Gatz SA, Benninghoff U, Schutz C, Schulz A, Honig M, Pannicke U, et al. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011;46(4):552–6.
15. Boztug H, Karitnig-Weiss C, Ausserer B, Renner ED, Albert MH, Sawalle-Belohradsky J, et al. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol. 2012;29(7):585–94.
16. Barlogis V, Galambrun C, Chambost H, Lamoureux-Toth S, Petit P, Stephan JL, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol. 2011;128(2):420--422.
17. Ghosh S, Schuster FR, Adams O, Babor F, Borkhardt A, Comoli P, et al. Haploidentical stem cell transplantation in DOCK8 deficiency - successful control of pre-existing severe viremia with a TCRass/CD19-depleted graft and antiviral treatment. Clin Immunol. 2014;152(1–2):111–4.
18. Metin A, Tavil B, Azik F, Azkur D, Ok-Bozkaya I, Kocabas C, et al. Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr Transplant. 2012;16(4):398–9.
19. Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014;133(5):1410--1419.
20. Crawford G, Enders A, Gileadi U, Stankovic S, Zhang Q, Lambe T, et al. DOCK8 is critical for the survival and function of NKT cells. Blood. 2013;122(12):2052–61.
21. Ham H, Guerrier S, Kim J, Schoon RA, Anderson EL, Hamann MJ, et al. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol. 2013;190(7):3661–9.
22. Mizesko MC, Banerjee PP, Monaco-Shawver L, Mace EM, Bernal WE, Sawalle-Belohradsky J, et al. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2013;131(3):840–8.
23. Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148(1):79–84.
24. Dasouki M, Okonkwo KC, Ray A, Folmsbeel CK, Gozales D, Keles S, et al. Deficient T cell receptor excision circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin Immunol. 2011;141(2):128–32.
25. McDonald DR, Massaad MJ, Johnston A, Keles S, Chatila T, Geha RS, et al. Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2010;126(6):1304--1305.
26. Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208(11):2305–20.
27. Sanal O, Jing H, Ozgur T, Ayvaz D, Strauss-Albee DM, Ersoy-Evans S, et al. Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol. 2012;32(4):698–708.
28. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141–54.
29. Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-Staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol. 2013;33(1):55–67.
30. Al-Herz W, Ragupathy R, Massaad MJ, Al-Attiyah R, Nanda A, Engelhardt KR, et al. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol. 2012;143(3):266–72.
31. Nehme NT, Pachlopnik Schmid J, Debeurme F, Andre-Schmutz I, Lim A, Nitschke P, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood. 2012;119(15):3458–68.
32. Jing H, Zhang Q, Zhang Y, Hill BJ, Dove CG, Gelfand EW, et al. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol. 2014;133(6):1667–75.
33. Pai SY, de Boer H, Massaad MJ, Chatila TA, Keles S, Jabara HH, et al. Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency. J Allergy Clin Immunol. 2014;134(1):221.–223.
34. Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol. 2014;133(2):529–34.
35. Kane A, Deenick EK, Ma CS, Cook MC, Uzel G, Tangye SG. STAT3 is a central regulator of lymphocyte differentiation and function. Curr Opin Immunol. 2014;28C:49–57.
36. Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol. 2011;18(1):42–8.
37. Aan de Kerk DJ, van Leeuwen EM, Jansen MH, van den Berg JM, Alders M, Vermont CL, et al. Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis. Clin Immunol. 2013;149(1):25–31.
38. Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012;119(19):4451–61.
39. Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012;13(6):612–20.